Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuroscience Letters

• Publication date

  2004-03-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEULET.2004.01.011PMID 15026161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine‐mediated blood pressure reaction

  2002cited by this paper
• Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats.

  2001cited by this paper
• Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

  2001cited by this paper
• Activation of I2‐imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors

  2000cited by this paper
• Effects of Core Body Temperature on Changes in Spinal Somatosensory-Evoked Potential in Acute Spinal Cord Compression Injury: An Experimental Study in the Rat

  2000cited by this paper
• Imidazolines and Pancreatic Hormone Secretion a

  1999cited by this paper
• Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands

  1998cited by this paper
• 'Seeing through a glass darkly': casting light on imidazoline 'I' sites.

  1998cited by this paper
• Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression.

  1997cited by this paper
• Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment.

  1996cited by this paper
• Clinical Pharmacology of Drugs Acting on Imidazoline and Adrenergic Receptors

  1995cited by this paper
• Potassium Channels, Imidazolines, and Insulin‐Secreting Cells fn1

  1995cited by this paper
• Exercise in Individuals With IDDM

  1994cited by this paper
• Agmatine: an endogenous clonidine-displacing substance in the brain.

  1994cited by this paper
• Pharmacological mechanisms of opioid analgesics.

  1993cited by this paper
• Keeping an eye on the I site: imidazoline-preferring receptors.

  1992cited by this paper
• Keeping an eye on the I site: imidazoline-prefemng receptors

  1992cited by this paper
• Dual action of clonidine on insulin release: suppression, but stimulation when α2-adrenoceptors are blocked

  1989cited by this paper
• Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment

  1987cited by this paper

• Exploring the clinical connections between epilepsy and diabetes mellitus: Promising therapeutic strategies utilizing agmatine and metformin

  2024cites this paper
• Novel Kinetic Resolution of Thiazolo-Benzimidazolines Using MAO Enzymes

  2023cites this paper
• Possible involvement of GABAergic system on central amygdala Mediated anxiolytic effect of agmatine in rats

  2023cites this paper
• Chronic Agmatine Treatment Prevents Olanzapine-induced Obesity and Metabolic Dysregulation in Female Rats.

  2022cites this paper
• Agmatine and glycolipid metabolism.

  2021cites this paper
• Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection

  2021cites this paper
• Agmatine Modulates Anxiety and Depression-like Behaviour in Diabetic Insulin-Resistant Rats.

  2020cites this paper
• Synthesis and biological evaluation of imidazoline derivatives as potential CNS and CVS agents.

  2020cites this paper
• The dynamics of actin filament polymerization in activated leukocytes under experimental diabetes mellitus against the background of agmatine administration

  2018cites this paper
• Effects of agmatine on cognitive functions during vascular dementia in biological aging through eNOS and BDNF expression

  2017cites this paper
• Canavanine induces insulin release via activation of imidazoline I3 receptors

  2015cites this paper
• Borne Identity: Leading Endogenous Suspects at Imidazoline Binding Sites

  2015cites this paper
• Biologically active compounds based on the privileged 2-imidazoline scaffold: The world beyond adrenergic/imidazoline receptor modulators.

  2015cites this paper
• Allantoin activates imidazoline I-3 receptors to enhance insulin secretion in pancreatic β-cells

  2014cites this paper
• Novel I1-Imidazoline Agonist S43126 Augment Insulin Secretion in Min6 Cells

  2012cites this paper
• Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I₂ receptor ligands.

  2011cites this paper
• Comparative effects of idazoxan, efaroxan, and BU 224 on insulin secretion in the rabbit: Not only interaction with pancreatic imidazoline I2 binding sites

  2010cites this paper
• ctivation of imidazoline I 2 B receptors by guanidine to increase glucose ptake in skeletal muscle of rats

  2009cites this paper
• Activation of imidazoline I(2B) receptors by guanidine to increase glucose uptake in skeletal muscle of rats.

  2009cites this paper
• ncrease of-endorphin secretion by agmatine is induced by activation of midazoline I 2 A receptors in adrenal gland of rats hin -

  2009cites this paper
• New analogues of agmatine with higher affinity to imidazoline receptors.

  2009cites this paper
• Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats.

  2009cites this paper
• Activation of I(2)-imidazoline receptors may ameliorate insulin resistance in fructose-rich chow-fed rats.

  2008cites this paper
• Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats

  2005cites this paper